Soft Tissue Sarcomas

Sultan, Iyad; Ortiz, Roberta; Ferrari, Andrea

doi:10.1007/978-1-4614-3891-5_21

Search citation statements

Order By: Relevance

Paper Sections

Select...

Patients and Data Collection1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2018

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 93 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our cohort included 3 groups: (I) bony sarcomas as osteosarcomas, chondrosarcomas, and primitive neuroectodermal tumor (PNET)/Ewing's sarcoma; (II) soft tissue sarcoma as fibromatosis/fibrosarcoma, pleomorphic undifferentiated sarcoma previously named malignant fibrous histiocytoma, dermatofibrosarcoma protuberans, synovial sarcoma, angiosarcoma, myxofibrosarcoma, rhabdomyosarcoma , myxoliposarcoma; (III) others as carcinomas, solitary plasma cell myeloma and lymphoma that were initially diagnosed as liposarcoma (9)(10)(11)(12).…”

Section: Patients and Data Collectionmentioning

confidence: 99%

Contributing factors to the outcome of primary malignant chest wall tumors

et al. 2017

View full text Add to dashboard Cite

Background: Primary malignant chest-wall tumors (PMCWTs) are a heterogeneous group of tumors.They require a special experience in designing resection and reconstruction. They account for less than 1% of all primary malignant tumors. This study is designed to clarify different factors contributing to the outcome of patients with PMCWTs in our institution. Methods: A retrospective study included 98 patients with pathology proven PMCWTs, treated at the National Cancer Institute (NCI), Cairo University, Egypt, during the past 10 years.

show abstract

Section: Patients and Data Collectionmentioning

confidence: 99%